These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35590091)

  • 1. Gas chromatography-mass spectrometry-based untargeted metabolomics reveals metabolic perturbations in medullary thyroid carcinoma.
    Jajin MG; Abooshahab R; Hooshmand K; Moradi A; Siadat SD; Mirzazadeh R; Chegini KG; Hedayati M
    Sci Rep; 2022 May; 12(1):8397. PubMed ID: 35590091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Metabolic Profiling of Human Thyroid Nodules by Gas Chromatography-Mass Spectrometry (GC-MS)-Based Untargeted Metabolomics.
    Abooshahab R; Hooshmand K; Razavi SA; Gholami M; Sanoie M; Hedayati M
    Front Cell Dev Biol; 2020; 8():385. PubMed ID: 32612989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.
    Zhan S; Li J; Wang T; Ge W
    Oncologist; 2018 Dec; 23(12):1415-1425. PubMed ID: 29739896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma metabolites analysis of patients with papillary thyroid cancer: A preliminary untargeted
    Razavi SA; Mahmanzar M; Nobakht M Gh BF; Zamani Z; Nasiri S; Hedayati M
    J Pharm Biomed Anal; 2024 Apr; 241():115946. PubMed ID: 38241910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
    J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study.
    Al-Akl NS; Khalifa O; Ponirakis G; Parray A; Ramadan M; Khan S; Chandran M; Ayadathil R; Elsotouhy A; Own A; Al Hamad H; Decock J; Alajez NM; Albagha O; Malik RA; El-Agnaf OMA; Arredouani A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted metabolomics analysis by gas chromatography/time-of-flight mass spectrometry of human serum from methamphetamine abusers.
    Wang T; Xu C; Xu S; Gao L; Blaženović I; Ji J; Wang J; Sun X
    Addict Biol; 2021 Nov; 26(6):e13062. PubMed ID: 34114299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of serum markers in medullary thyroid carcinoma].
    Han XD; Lu RQ; Hu HY; Guo L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1468-1474. PubMed ID: 34963245
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
    Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
    Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
    [No Abstract]   [Full Text] [Related]  

  • 11. GC-MS-based untargeted metabolic profiling of malignant mesothelioma plasma.
    Wang D; Zhu J; Li N; Lu H; Gao Y; Zhuang L; Chen Z; Mao W
    PeerJ; 2023; 11():e15302. PubMed ID: 37220527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients.
    Romeo P; Colombo C; Granata R; Calareso G; Gualeni AV; Dugo M; De Cecco L; Rizzetti MG; Zanframundo A; Aiello A; Carcangiu ML; Gloghini A; Ferrero S; Licitra L; Greco A; Fugazzola L; Locati LD; Borrello MG
    Endocr Relat Cancer; 2018 Mar; 25(3):217-231. PubMed ID: 29298817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
    Kartal Baykan E; Erdoğan M
    Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
    Guo S; Qiu L; Wang Y; Qin X; Liu H; He M; Zhang Y; Li Z; Chen X
    Anal Bioanal Chem; 2014 Jul; 406(18):4357-70. PubMed ID: 24842401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma.
    Xu Y; Zheng X; Qiu Y; Jia W; Wang J; Yin S
    J Proteome Res; 2015 Aug; 14(8):3315-21. PubMed ID: 26130307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic approach to thyroid cancer based on amino acid metabolomics in saliva by ultra-performance liquid chromatography with high resolution mass spectrometry.
    Zhang J; Wen X; Li Y; Zhang J; Li X; Qian C; Tian Y; Ling R; Duan Y
    Talanta; 2021 Dec; 235():122729. PubMed ID: 34517597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma.
    Censi S; Bertazza L; Piva I; Manso J; Benna C; Iacobone M; Mondin A; Plebani M; Faggian D; Galuppini F; Pennelli G; Barollo S; Mian C
    Front Endocrinol (Lausanne); 2021; 12():647369. PubMed ID: 33854485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical and clinical validation of pairwise microRNA expression analysis to identify medullary thyroid cancer in thyroid fine-needle aspiration samples.
    Ciarletto AM; Narick C; Malchoff CD; Massoll NA; Labourier E; Haugh K; Mireskandari A; Finkelstein SD; Kumar G
    Cancer Cytopathol; 2021 Mar; 129(3):239-249. PubMed ID: 33017868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation on the expression of miRNAs including miR-144 and miR-34a in plasma samples of RET-positive and RET-negative medullar thyroid carcinoma patients.
    Shabani N; Sheikholeslami S; Paryan M; Zarif Yeganeh M; Tavangar SM; Azizi F; Mohammadi-Yeganeh S; Hedayati M
    J Cell Physiol; 2020 Feb; 235(2):1366-1373. PubMed ID: 31297834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.